AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
1.040
-0.020 (-1.89%)
Mar 9, 2026, 4:00 PM EDT - Market closed
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $26.82 million as of March 9, 2026. Its market cap has increased by 191.64% in one year.
Market Cap
26.82M
Enterprise Value
39.15M
1-Year Change
191.64%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $26.82M, a decrease of -57.87%. That is a compound annual growth rate of -16.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 26.82M | 105.96% |
| Dec 31, 2025 | 13.02M | -39.67% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | 63.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 27.78M |
| Kyntra Bio | 27.67M |
| BriaCell Therapeutics | 27.53M |
| IGC Pharma | 27.39M |
| Cue Biopharma | 27.35M |
| Evaxion | 26.86M |
| Passage Bio | 26.70M |
| Exicure | 26.45M |